Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Enhancing immune response can improve cancer treatment effectiveness.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Enhancing Tregs can protect against alopecia areata.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

B cells can both help and hinder the body's defense against melanoma.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Prostanoids help regulate immune cells, affecting inflammation and cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.